Oncotarget: Targeting engineered cytokine with interleukin to the neovasculature of tumors
Bioengineer.org,
“The results suggest that this product, or similar fusion proteins featuring an N-terminal fusion in the diabody format, may…
“The results suggest that this product, or similar fusion proteins featuring an N-terminal fusion in the diabody format, may…
Oncotarget recently published "Targeting an engineered cytokine with interleukin-2 and interleukin-15 activity to the…